Correlation Between Day One and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Day One and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Day One and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Hepion Pharmaceuticals.
Diversification Opportunities for Day One and Hepion Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Day and Hepion is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Day One i.e., Day One and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Day One and Hepion Pharmaceuticals
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.42 times more return on investment than Hepion Pharmaceuticals. However, Day One Biopharmaceuticals is 2.38 times less risky than Hepion Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 2,145 in Day One Biopharmaceuticals on August 24, 2024 and sell it today you would lose (773.00) from holding Day One Biopharmaceuticals or give up 36.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Day One Biopharmaceu |
| Hepion Pharmaceuticals |
Day One and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Hepion Pharmaceuticals
The main advantage of trading using opposite Day One and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Day One vs. Lyra Therapeutics | Day One vs. Hookipa Pharma | Day One vs. Cingulate Warrants | Day One vs. SAB Biotherapeutics |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |